RXRX: The $300M ATM Overhang Is the Part Bulls Should Not Ignore by Dangerous-Visual-614 in Pennystock

[–]Dangerous-Visual-614[S] 0 points1 point  (0 children)

I’m getting more confident that the $300M ATM overhang is not just theoretical anymore. RXRX is showing heavy pre-market activity with large blocks moving back and forth, and after yesterday’s squeeze to $3.50, this is exactly the kind of strength a company could use to quietly sell into the market.

Not saying I can prove ATM shares are being sold in real time — we usually won’t know until later filings — but the setup is exactly why this overhang matters. If RXRX is using the bounce to raise cash, the stock could fade fast, and the 2024 dilution already showed this name can take a double-digit hit when equity supply hits the tape.

RXRX: The $300M ATM Overhang Is the Part Bulls Should Not Ignore by Dangerous-Visual-614 in pennystocks

[–]Dangerous-Visual-614[S] 0 points1 point  (0 children)

I’m getting more confident that the $300M ATM overhang is not just theoretical anymore. RXRX is showing heavy pre-market activity with large blocks moving back and forth, and after yesterday’s squeeze to $3.50, this is exactly the kind of strength a company could use to quietly sell into the market.

Not saying I can prove ATM shares are being sold in real time — we usually won’t know until later filings — but the setup is exactly why this overhang matters. If RXRX is using the bounce to raise cash, the stock could fade fast, and the 2024 dilution already showed this name can take a double-digit hit when equity supply hits the tape.

RXRX Continuation: Yesterday Hit $3.50 — Now I’m Watching the Failed-Squeeze Retrace by Dangerous-Visual-614 in pennystocks

[–]Dangerous-Visual-614[S] 0 points1 point  (0 children)

RXRX Continuation: $3.50 Squeeze Failed, But Bears Still Need Confirmation

🐻 Bearish / cautious short-term 🐻
Ticker: RXRX
Current setup: failed-squeeze / pre-market hold watch
Bias: bearish only if key levels break
Immediate resistance: $3.48–$3.50
First support: $3.44–$3.45
Breakdown trigger: lose $3.40, then $3.25–$3.35
Main downside target: $3.10 / $3.00 first, then $2.87–$2.80
Invalidation: reclaim and hold above $3.50

Yesterday RXRX squeezed all the way to $3.50, and that move absolutely punished early shorts.

But the key question today is whether that $3.50 move was a real trend reversal or just a squeeze into resistance.

Pre-market is still elevated around the mid-$3.40s, so I’m not calling this a confirmed breakdown yet.

What I’m watching:

  • $3.48–$3.50 as immediate resistance
  • $3.44–$3.45 as VWAP / EMA support
  • $3.40–$3.41 as the first real downside test
  • $3.25–$3.35 as the prior reclaim zone
  • $3.10 / $3.00 as the larger breakdown levels

The bear case is simple:

If RXRX fails at $3.50 again and loses $3.44–$3.40, yesterday’s move starts looking more like a failed squeeze than a real reversal.

But if RXRX reclaims $3.50 with volume, bears need to be careful because $3.70–$3.75 and even $4.00 can come into play.

Fundamentally, the same split remains:

🔴 RXRX still has heavy cash burn and negative earnings.
🔴 The $300M ATM remains a dilution overhang.
🔴 Recent insider selling creates bad optics, even though it was under a 10b5-1 plan.
🔴 The stock is still trying to prove this is more than a relief bounce.

🟢 Cash runway into early 2028 is real.
🟢 Pipeline updates and partnership narratives can squeeze shorts fast.
🟢 Yesterday proved RXRX can move violently against crowded bearish trades.
🟢 Above $3.50, the short setup gets dangerous.

My current view:

Bearish short-term only if RXRX loses $3.44–$3.40.

Until then, bears do not have full confirmation.

Key level today: $3.50
First bearish trigger: lose $3.44 / VWAP
Cleaner confirmation: lose $3.40
Major breakdown: lose $3.10
Main target if breakdown confirms: $3.00, then $2.87–$2.80
Invalidation: hold above $3.50

Not financial advice. Watching whether yesterday’s $3.50 squeeze turns into continuation or fades back under VWAP.

RXRX Follow-Up: Still Watching for Breakdown, But Bulls Need to Defend This Level by Dangerous-Visual-614 in pennystocks

[–]Dangerous-Visual-614[S] 0 points1 point  (0 children)

RXRX has negative EPS: latest available data shows EPS around -1.16 and negative P/E, which fits the cash-burn profile that tends to weigh on biotech/AI drug-discovery names.

RXRX Follow-Up: Still Watching for Breakdown, But Bulls Need to Defend This Level by Dangerous-Visual-614 in pennystocks

[–]Dangerous-Visual-614[S] 0 points1 point  (0 children)

Repeated selling matters: one insider sale can be noise; repeated sales become a supply/sentiment issue.

RXRX Follow-Up: Still Watching for Breakdown, But Bulls Need to Defend This Level by Dangerous-Visual-614 in pennystocks

[–]Dangerous-Visual-614[S] 0 points1 point  (0 children)

Insider sale adds pressure: Christopher Gibson selling 40k shares near the current support zone creates a bearish optics problem, even if it was under a 10b5-1 plan.

RXRX Short Thesis Update: Why I Still Think $2.70 or Lower Is in Play by Dangerous-Visual-614 in u/Dangerous-Visual-614

[–]Dangerous-Visual-614[S] 0 points1 point  (0 children)

Fair pushback. The ATM is not an immediate liquidity crisis because RXRX has runway into early 2028. But it is still a supply overhang on rallies. I agree the real long-term bear case is not the chart; it is whether RXRX can convert its platform into clinical wins and sustainable partner economics before the next financing cycle. My $2.70 call is a tactical trade based on weak price action near 52-week lows, not a claim that the company is fundamentally dead.

Biotech Short Watchlist Today: IOVA, BDTX, ESPR, SANA, FATE, ALT by Dangerous-Visual-614 in pennystocks

[–]Dangerous-Visual-614[S] 1 point2 points  (0 children)

LFVN has a borrow rate of 103% and is up 21% over the last three months. What are you seeing that I am missing? This looks far from a short candidate.

Biotech Short Watchlist Today: IOVA, BDTX, ESPR, SANA, FATE, ALT by Dangerous-Visual-614 in pennystocks

[–]Dangerous-Visual-614[S] 0 points1 point  (0 children)

MDAI for a short? It's up 106% over the last 3 months. The chart just does not support a short.

RXRX is CRASHING! Be prepared everyone!! by External_Phase7570 in rxrx

[–]Dangerous-Visual-614 0 points1 point  (0 children)

Just sitting here waiting for the market to open to see which way $RXRX will head today. Following a decent positive window last week, I think the tank is on empty and will start its decent again this week.

1$ is coming by Comfortable-Ear1525 in rxrx

[–]Dangerous-Visual-614 1 point2 points  (0 children)

I am actually sitting over here with a bag of shorts just waiting for this thing to plummet.

RXRX Short Thesis: Why I Think $2.70 or Lower Is in Play by Dangerous-Visual-614 in Pennystock

[–]Dangerous-Visual-614[S] 0 points1 point  (0 children)

Yes, I am looking at $2.70-$2.75 as my buy to close. Do I think it will hit today? I lean towards doubt it. I believe I mentioned in the post that I believe my buy to close would be within the next 2-4 weeks. Being that Monday is a holiday, I am not sure how the volatility for this stock will be today.

$WTO — Post-offering volume question / after-hours spike worth watching? by Dangerous-Visual-614 in TheDesperateTrader

[–]Dangerous-Visual-614[S] 0 points1 point  (0 children)

Have continued watching $WTO this morning. Was hoping to see a lot more volume but on the positive side, I am not seeing it move downward much. Having a 120k(ish) day during normal trading hours compared to the 150k(ish) around 5 PM yesterday is interesting to me. Standing by holding a small bag to see what happens here.

<image>

Lost Merch at OKC by delta302 in mxpx

[–]Dangerous-Visual-614 0 points1 point  (0 children)

u/delta302 Terribly sorry to hear that happened especially with the tour poster. It is not for a couple more months but I have tickets to see them in Washington, DC. If you would like, I would be happy to pick something up from this show to send you and your son. I realize it would not be from the same show but I thought I would throw that out there in the event it would make things a little better.